Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 8 Component(s), Includes Credits

    Intended for clinical, veterinary, and public health laboratories, review the gaps associated with defining, detecting, and reporting MDRO.

    Register for this free course to claim 1.5 P.A.C.E. credits from the January 2024 education session and receive access to the on-demand recording and slides.

    Intended for clinical, veterinary, and public health laboratories, review the gaps associated with defining, detecting, and reporting MDRO. 

    Learning Objectives:

    1. Describe gaps that are impacting the definition, detection, and reporting MDRO in clinical, veterinary, and public health laboratories.
    2. Discuss processes that can be implemented to fill the gaps.
    3. Identify current resources that may help fill the gaps.

    The on-demand recording will be available to view on January 26th. 

    CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

    April Bobenchik, PhD, D(ABMM)

    Medical Director Microbiology and Associate Professor

    Penn State Health and College of Medicine

    Dr. Bobenchik is a board-certified clinical microbiologist with over 20 years of experience working in the laboratory. She is currently the Medical Director of Microbiology and Virology at Penn State Hershey Medical Center and Associate Professor of Pathology at Penn State College of Medicine. She has been a volunteer with CLSI since 2013 and is the current co-chair of the text and table working group and a member of the outreach working group.

    Kelli Maddock, MS, MLS (ASCP) M

    Senior Research Scholar

    North Dakota State University

    Kelli Maddock is the Section Head of the Microbiology and Biosafety Level-3 laboratories at the NDSU Veterinary Diagnostic Laboratory. She holds BS and MS degrees in Medical Laboratory Science and has work experience in human and veterinary laboratory medicine spanning 14 years. Kelli is also Doctor of Public Health (DrPH) candidate in the Clinical Laboratory Science and Practice concentration through the University of South Florida.

    Paula M. Snippes Vagnone, MT(ASCP)

    Supervisor, Microbiology Laboratory

    Minnesota Department of Health St. Paul

    Paula Vagnone, MT (ASCP) is the Microbiology Unit Supervisor in the Infectious Disease Laboratory (IDL) of the Minnesota Department of Health (MDH), overseeing the general microbiology, mycobacterial, fungal, and antibiotic/antifungal testing areas of the laboratory. She serves as the Laboratory Coordinator of the Antibiotic Resistance Laboratory Network Central Region, a liaison-type role between the MDH Central Region Lab, the eight state public health laboratories and the epidemiology health care–associated infection coordinators in the region. 

    Allison Brown, PhD, MPH

    Director, Office of Laboratory Strategies and Analytics

    Centers for Disease Control and Prevention

    Allison Brown, PhD, MPH, is the Associate Director of the Office of Laboratory Strategies and Analytics (OLSA) in the Division of Healthcare Quality Promotion at CDC. Dr. Brown’s team leads CDC’s Antibiotic Resistance Laboratory Network activities focused on detection and characterization of novel resistance in healthcare-associated infections. 

    Stella Antonara, PhD, D(ABMM) (Moderator)

    Medical Director of Microbiology

    OhioHealth

  • Contains 7 Component(s), Includes Credits

    This webinar will focus on how the 2023 BIT can assist the laboratory with MIC breakpoint changes and will not cover disk diffusion. Speakers will provide examples from three different commercial AST systems.

    Objectives:

    -Discuss the updated College of American Pathologists (CAP) checklist items and how the 2023 Breakpoint Implementation Toolkit (BIT) can be used to meet regulatory needs.
    -Understand antimicrobial susceptibility testing (AST) system-specific steps to complete the 2023 BIT.
    -Develop a strategy for updating to current minimum inhibitory concentration (MIC) breakpoints.

    Earn 1.0 P.A.C.E.®️ credits.

    Review the BIT Toolkit

    CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

    Romney Humphries, PhD D(ABMM) (Moderator)

    Professor, Department of Pathology, Microbiology and Immunology

    Vanderbilt University Medical Center

    Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine. Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

    Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

    April Abbott, Ph.D., D(ABMM)

    Director, Microbiology and Molecular Diagnostics Deaconess Health System and Adjunct Assistant Professor, Microbiology and Immunology Indiana University School of Medicine

    Deaconess Health System and Indiana University School of Medicine

    Dr. Abbott is the Director of the Microbiology and Molecular Diagnostics Laboratory for Deaconess Health System, a large, multi-hospital network in Indiana, Kentucky, and Illinois. She is an American Board of Medical Microbiology diplomate and adjunct Assistant Professor at Indiana University School of Medicine and is on the Journal of Clinical Microbiology Editorial Board and serves on local and regional microbiology committees.

    Dr. Abbott is a member of the Clinical Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing (AST) Subcommittee, including the Outreach Working Group. Her main area of interest is in antimicrobial susceptibility testing and resistance. She has a number of publications, book chapters, and presentations related to susceptibility testing, antimicrobial resistance, antimicrobial stewardship and diagnostic stewardship.

     

     

     

     

    Felicia M. Rice, MT (ASCP)

    Technical Specialist II, Microbiology Laboratory and Instructor in Laboratory Medicine and Pathology at Mayo Clinic Hospital

    Mayo Clinic

    Felicia Rice, MT (ASCP) is currently the Technical Specialist II in the Microbiology Laboratory and an Instructor in Laboratory Medicine and Pathology at Mayo Clinic Hospital in Phoenix, Arizona. She is a member of the Text and Tables Working Group and is the Secretary for the Outreach Working Group.

    Tsigereda Tekle, MT(ASCP)

    Lead Medical Technologist

    Johns Hopkins University Hospital

    Tsigereda Tekle MT (ASCP) graduated from Washington University with a BS in Medical Technology, and has worked in the Johns Hopkins Hospital Microbiology Department, where she is a Lead Medical Technologist of Antimicrobial Susceptibility Testing, for over 20 years. She is a CLSI member and serves on CLSI’s M45 Working Group. Ms. Tekle has also contributed her expertise to many posters and publications throughout the years. 

  • Contains 1 Component(s) Recorded On: 08/11/2023

    Learn how to expand CLSI access across your organization with this free member webinar. Diana L. Kremitske, MT(ASCP), MS, MHA, Barbara Booth, BS, MT (ASCP) CPHQ and Jeana Houseman, MHSA, DLM(ASCP)CM will be joining us to discuss how expanding CLSI access with a Health System membership has been beneficial for their organizations.

    Learn how to expand CLSI access across your organization with this free member webinar. Diana L. Kremitske, MT(ASCP), MS, MHA, Barbara Booth, BS, MT (ASCP) CPHQ and Jeana Houseman, MHSA, DLM(ASCP)CM will be joining us to discuss how expanding CLSI access with a Health System membership has been beneficial for their organizations. 

    Topics covered include: 

    • What is Health System membership?
    • The member benefits and pricing structure of Health System membership.
    • An overview of our current Health System members.
    • The benefits to your organization of being a Health System member.
    • How to share the system benefits with other staff to ensure your organization is making the most of its membership.

     

    Diana L. Kremitske, MHA, MS, MLS(ASCP)

    Vice President Institute Operations, Laboratory Medicine

    Geisinger

    Diana L. Kremitske has 37 years’ experience in the laboratory profession with most of those years spent in hospitals of an integrated health system. Currently, Ms. Kremitske holds an executive leadership role as Vice President in the Diagnostic Medicine Institute at Geisinger - overseeing laboratory operations, and system courier services at eight hospital campuses and numerous clinics. She also participates in overseeing Geisinger’s Patient Blood Management Program. She received her bachelor’s degree in Medical Technology and a master’s degree in Chemistry and a master’s degree in Health Care Administration all from the University of Scranton, Scranton, Pa.

    In addition to her laboratory career at Geisinger, Ms. Kremitske has coordinated a large scale, regional implementation project for an electronic medical record in physician practices at Geisinger and assisted in designing, as well as supporting best practice initiatives systemwide in the organization’s primary care network. She also has experience in the realm of laboratory quality, with part of her career as Laboratory Service Improvement Coordinator and contributor to the early development of a laboratory error reporting mechanism and database. She has also directed laboratory integration activities and process standardization efforts in hospital laboratory acquisitions and is involved in appropriate test utilization efforts.

    Ms. Kremitske is a member of the ASCP and has been an active volunteer for the society since 2009, which includes being Chair of the Council of Laboratory Professionals in 2014-2015, and her current role as Chair of the Commission on Membership and Treasurer of the ASCP.

    Ms. Kremitske is also a member of the American College of Health Care Executives and the American Society for Clinical Laboratory Science.

     

    Barbara Booth, BS, MT (ASCP) CPHQ

    Laboratory Quality Systems Senior Coordinator

    Geisinger

    Barbara Booth, BS, MT (ASCP) CPHQ is the Laboratory Quality Systems Senior Coordinator at Geisinger Wyoming Valley Medical Center Wilkes Barre, Pennsylvania. She provides leadership in regulatory and quality management activities for the Geisinger Laboratory Medicine.  Barbara earned a BS degree in Medical Technology from Bloomsburg University of Pennsylvania, is certified in Just Culture and is a volunteer inspector for the College of American Pathologists.

     

    Jeana Houseman, MHSA, DLM(ASCP)CM

    Director of Quality, Patient Safety and Accreditation for Laboratories

    HealthPartners

    Jeana Houseman, MHSA, DLM(ASCP)CM is the Director of Quality, Patient Safety and Accreditation for Laboratories at HealthPartners, a large integrated health system based in Minnesota. In this role, she provides leadership and oversight for laboratory safety, quality improvement, education, data analytics, document control, regulatory and accreditation. Jeana has 18 years of healthcare experience, including roles in clinical microbiology, infection prevention and hospital regulatory compliance. She has previously spoken at regional and national conferences on the topics of microbiology testing, diagnostic stewardship, and high reliability in the lab. Her current areas of interest are regulatory compliance, high reliability, and test utilization.

    Jessica (Chumaceiro) Tredway

    Customer Relationship Manager, CLSI

    Clinical and Laboratory Standards Institute

    Jessica Tredway is CLSI's Customer Relationship Manager. Her responsibilities include building, retaining, maintaining, and fostering relationships between CLSI and its stakeholders, including members, customers, volunteers and vendors.

  • Contains 1 Component(s)

    This webinar presents an overview of MM09: Human Genetic and Genomic Testing Using Traditional and High-Throughput Nucleic Acid Sequencing Methods, 3rd Edition

    At the conclusion of this webinar, you will: 

    • Understand the next-generation sequencing (NGS) test development lifecycle
    • Learn the value of step-by-step guidance provided by instructional worksheets
    • Understand the differences between the previous and revised MM09 versions
    • Recognize evolving (up and coming) NGS sequencing applications (ie, Human Leukocyte Antigen (HLA), RNA (RNA Seq), noninvasive prenatal testing (NIPT), and liquid biopsy)

    Birgit Funke, PhD, FACMG

    Dr. Funke received her PhD from the University of Würzburg, Germany and trained as a postdoctoral fellow at the Albert Einstein College of Medicine where she identified the gene for 22q11 deletion syndrome.  She is Board certified in Clinical Molecular Genetics, served as Associate Professor of Pathology at Harvard Medical School where she was among the first worldwide to implement clinical NGS in 2011 at the Laboratory for Molecular Medicine in Cambridge. From 2017 to 2023, Dr. Funke has served in several leadership roles in commercial genetic testing laboratories where she focused on implementing and scaling testing for hereditary cancer, cardiovascular disease as well as proactive genomic applications.

    Academically, Dr. Funke is known for her work on the genetic landscape of inherited cardiomyopathies, leading international efforts to develop professional guidelines for clinical genomic knowledge curation, as well as development of cutting edge clinical genomic tests. Her long-term goal is to help increase the use of genomic testing in clinical care, especially for disease prevention.

     

  • Contains 3 Component(s), Includes Credits

    Current methods for AST of Mycobacterium tuberculosis complex (MTBC), as well as new and evolving standards for non-tuberculous Mycobacterium spp. will be discussed.

    Susceptibility testing of mycobacteria will be discussed in this upcoming webinar. Speakers will: 

    • Discuss current methods for phenotypic and genotypic antimicrobial susceptibility testing (AST) of Mycobacterium tuberculosis complex (MTBC).
    • Review new and evolving standards for non-tuberculous Mycobacterium spp.
    • Evaluate updated guidance from the forthcoming CLSI Standard M24.
    • Review recent changes that impact AST for MTBC.


    ​Barbara A. Brown-Elliott MS, MT(ASCP), SM

    Professor of Microbiology and Associate Director of the Mycobacteria/Nocardia Laboratory at the University of Texas Health Science Center at Tyler (UTHSCT)

    University of Texas Health Science Center at Tyler (UTHSCT)

    Barbara A. Brown-Elliott MS, MT(ASCP), SM is currently a Professor of Microbiology and Associate Director of the Mycobacteria/Nocardia Laboratory at the University of Texas Health Science Center at Tyler (UTHSCT). She has supervised the UTHSCT laboratory since 1988. Before coming to the UTHSCT, she served as a clinical microbiology supervisor, a consultant for a clinical microbiology reference laboratory, and a microbiology Adjunct Professor in medical technology. She is the author and/or co-author of more than 300 peer-reviewed articles and chapters on nontuberculous mycobacteria (NTM), Nocardia and other aerobic actinomycetes, with over 100 publications on antimicrobial susceptibility testing and resistance mechanisms. She has been a member of the American Society for Microbiology (ASM) since 1978 and is a frequent speaker at local, national, and international meetings. She is a member of the Clinical and Laboratory Standards Institute (CLSI) Antimycobacterial Susceptibility Subcommittee (Currently revised as the Antimycobacterial Susceptibility Working Group). She is a 2009 recipient of the Becton Dickinson Gardner Middlebrook Award for Outstanding Work in Mycobacteriology, the ASM Scherago-Rubin Award for outstanding clinical microbiologist in 2013, and an ASM Distinguished Lecturer from 2019-2020. 

    Marie-Claire Rowlinson, PhD, D(ABMM)

    Chief of Bacterial Diseases at the Wadsworth Center, New York State Department of Health

    Wadsworth Center, New York State Department of Health

    Dr. Marie-Claire Rowlinson received her undergraduate and doctoral degrees in Medical Microbiology in the UK and then completed a post-doctoral fellowship in Medical and Public Health Laboratory Microbiology at University of California, Los Angeles. Following the fellowship, Dr. Rowlinson worked with the Association of Public Health Laboratories (APHL) in their Global Health program, building laboratory capacity in Eastern Europe, Africa, and the Caribbean. From 2012 to 2021, she held the position of Assistant Laboratory Director and CLIA Laboratory Director at the Florida Department of Health, Bureau of Public Health Laboratories in Jacksonville. Since September 2021, Dr. Rowlinson is the Chief of Bacterial Diseases at the Wadsworth Center, New York State Department of Health. Dr. Rowlinson’s expertise is in infectious disease diagnostics, in particular molecular diagnostics, tuberculosis, and global health. She continues to work closely with the Association of Public Health Laboratories and is the Chair of the APHL Infectious Diseases Committee and a Member of the TB Subcommittee. She also continues to work with APHL on an international level, consulting with the Global Health program, most recently working with the Ukraine Ministry of Health. Dr. Rowlinson is a Member of the College of American Pathologists Microbiology Committee.

    ​Romney Humphries, PhD D(ABMM) (Moderator)

    Director of Infectious Diseases Laboratories and Director of the Division of Laboratory Medicine, Vanderbilt University Medical Center

    Vanderbilt University Medical Center

    Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine.

    Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

    She worked at UCLA as an assistant professor in Pathology and laboratory medicine from 2010–2017 and was the section chief for clinical microbiology from 2012–2017. She then took on the role of Chief Scientific Officer at Accelerate Diagnostics from 2017–2020 before returning to academia in 2020, at VUMC.

    Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

    Dr. Humphries is an editor for the Journal of Clinical Microbiology and Clinical Infectious Diseases. She is a member of the Clinical and Laboratory Standards Institute (CLSI) Antibiotic Susceptibility Testing (AST) Subcommittee, the College of American Pathologists (CAP) Microbiology Committee, the American Society for Microbiology (ASM) Professional Practices Committee, and vice-chair of the Infectious Diseases Society of America Diagnostics Committee.

    She is the author of over 150 peer-reviewed articles, numerous book chapters, and has lectured globally on the topics of antimicrobial resistance and diagnostic microbiology. Dr. Humphries is the 2022 ASM awardee for Leadership and Research in Clinical Microbiology. She is a fellow of the American Academy of Microbiology, and the Infectious Diseases Society of America.


  • Contains 3 Component(s), Includes Credits

    CLSI 2023 AST Webinar: M100-Ed33 Updates

    -Identify the major changes found in the updated edition of CLSI’s M100. 

    -Design a strategy for implementing the new 33rd Edition into laboratory practices.

    -Communicate significant AST and reporting changes to staff.

    ​Romney Humphries, PhD D(ABMM)

    Director of Infectious Diseases Laboratories and Director of the Division of Laboratory Medicine, Vanderbilt University Medical Center

    Vanderbilt University Medical Center

    Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine.

    Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

    She worked at UCLA as an assistant professor in Pathology and laboratory medicine from 2010–2017 and was the section chief for clinical microbiology from 2012–2017. She then took on the role of Chief Scientific Officer at Accelerate Diagnostics from 2017–2020 before returning to academia in 2020, at VUMC.

    Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

    Dr. Humphries is an editor for the Journal of Clinical Microbiology and Clinical Infectious Diseases. She is a member of the Clinical and Laboratory Standards Institute (CLSI) Antibiotic Susceptibility Testing (AST) Subcommittee, the College of American Pathologists (CAP) Microbiology Committee, the American Society for Microbiology (ASM) Professional Practices Committee, and vice-chair of the Infectious Diseases Society of America Diagnostics Committee.

    She is the author of over 150 peer-reviewed articles, numerous book chapters, and has lectured globally on the topics of antimicrobial resistance and diagnostic microbiology. Dr. Humphries is the 2022 ASM awardee for Leadership and Research in Clinical Microbiology. She is a fellow of the American Academy of Microbiology, and the Infectious Diseases Society of America.


    April Bobenchik, PhD, D(ABMM)

    Medical Director Microbiology and Associate Professor

    Penn State Health and College of Medicine

    Dr. Bobenchik is a board-certified clinical microbiologist with over 20 years of experience working in the laboratory. She is currently the Medical Director of Microbiology and Virology at Penn State Hershey Medical Center and Associate Professor of Pathology at Penn State College of Medicine. She has been a volunteer with CLSI since 2013 and is the current co-chair of the text and table working group and a member of the outreach working group.

    Janet A. Hindler, MCLS, MT(ASCP), F(AAM) (Moderator)

    Consultant, Los Angeles County Department of Public Health

    Ms. Hindler has worked as a clinical microbiologist for over 50 years, including 40 years at UCLA Health System. Currently, she works as a consultant for the Los Angeles County Department of Public Health.  Janet has been a volunteer with CLSI for nearly 3 decades.

  • Contains 3 Component(s), Includes Credits

    Summary: CLSI 2023 AST Webinar: M100-Ed33 Updates

    -Identify the major changes found in the updated edition of CLSI’s M100. 

    -Design a strategy for implementing the new 33rd Edition into laboratory practices.

    -Communicate significant AST and reporting changes to staff.

    ​Romney Humphries, PhD D(ABMM)

    Director of Infectious Diseases Laboratories and Director of the Division of Laboratory Medicine, Vanderbilt University Medical Center

    Vanderbilt University Medical Center

    Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine.

    Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

    She worked at UCLA as an assistant professor in Pathology and laboratory medicine from 2010–2017 and was the section chief for clinical microbiology from 2012–2017. She then took on the role of Chief Scientific Officer at Accelerate Diagnostics from 2017–2020 before returning to academia in 2020, at VUMC.

    Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

    Dr. Humphries is an editor for the Journal of Clinical Microbiology and Clinical Infectious Diseases. She is a member of the Clinical and Laboratory Standards Institute (CLSI) Antibiotic Susceptibility Testing (AST) Subcommittee, the College of American Pathologists (CAP) Microbiology Committee, the American Society for Microbiology (ASM) Professional Practices Committee, and vice-chair of the Infectious Diseases Society of America Diagnostics Committee.

    She is the author of over 150 peer-reviewed articles, numerous book chapters, and has lectured globally on the topics of antimicrobial resistance and diagnostic microbiology. Dr. Humphries is the 2022 ASM awardee for Leadership and Research in Clinical Microbiology. She is a fellow of the American Academy of Microbiology, and the Infectious Diseases Society of America.


    April Bobenchik, PhD, D(ABMM)

    Medical Director Microbiology and Associate Professor

    Penn State Health and College of Medicine

    Dr. Bobenchik is a board-certified clinical microbiologist with over 20 years of experience working in the laboratory. She is currently the Medical Director of Microbiology and Virology at Penn State Hershey Medical Center and Associate Professor of Pathology at Penn State College of Medicine. She has been a volunteer with CLSI since 2013 and is the current co-chair of the text and table working group and a member of the outreach working group.

  • Contains 2 Component(s)

    Learn about improving antimicrobial stewardship with new approaches in thoughtful antimicrobial reporting. Speakers: Nicole Scangarella-Oman, MS April M. Bobenchik, PhD, D(ABMM), MT(ASCP) Patricia (Trish) Simner, PhD, D(ABMM) Nathan P. Wiederhold, PharmD Stephen Cole, VMD, MS, DACVM

    Learn about improving antimicrobial stewardship with new approaches in thoughtful antimicrobial reporting.

    By participating in this program, you will learn about: 

    • The changes in the 33rd edition of M100, including those to Tables 1. 
    • Tables/information with CLSI Antifungal Susceptibility documents similar to Table 1 in M100.
    • The work of the Antifungal Susceptibility Testing subcommittee WG on intrinsic resistance with examples of intrinsic antifungal resistance.
    • Examples where definition of intrinsic resistance is not met but antifungal susceptibility testing is still not recommended.
    • Selecting antimicrobials to test and report for veterinary specimens.
  • Contains 2 Component(s) Recorded On: 11/08/2022

    Helpful information about your CLSI membership will be presented in this Webinar for delegates and alternate delegates.

    Helpful information about your CLSI membership will be presented in this Webinar for active CLSI Delegates and Alternate Delegates, including: 

    • Who CLSI is, how we make a difference, and who our members are.
    • An introduction to our new CEO, Barb Jones, PhD.
    • Your role as a Delegate.
    • A volunteering general overview.
    • A high-level membership benefits review.
    • A step-by-step walkthrough of “My CLSI.”
    • A demo of our online library, eCLIPSE.
    • Accreditation resources.
    • New CLSI documents and products.
    • Upcoming publications and products. 

    Barb Jones, PhD

    CEO, CLSI

    Clinical and Laboratory Standards Institute

    Dr. Barb Jones was appointed as Chief Executive Officer of CLSI on May 15, 2022. She is the third CEO in CLSI's 54-year history. Dr. Jones’ experience includes operations leadership, laboratory management, pharmaceutical and quality standards development, regulatory policy, and business development at both the national and international levels. Prior to her role as CLSI’s CEO, Barb was Senior Vice President, Scientific Operations and Regulatory Affairs at Vyant Bio in San Diego, California.

    In her role as Vice President at the United States Pharmacopeia (USP), Dr. Jones directed the work of more than 200 global scientists and oversaw the “Gold Standard” for reference materials for the US and more than 150 countries worldwide. As a scientist and researcher for the National Institute of Standards and Technology (NIST), she served as Science Advisor for the Biochemical Sciences Division, and was appointed by the NIST Director as Advisor to the US House of Representatives Committee on Science and Technology. In this role, she developed analytical techniques for lab-on-a-chip technology and coordinated the expansion of chemical and biological weapons counterterrorism standards for the US Department of Homeland Security.

    Additionally, she has provided critical advisement on the viability of acquisitions and technologies, particularly in pharmaceutical and medical device and diagnostic development. She also has advised international policy makers, key scientists, and business leaders around the world on pharmaceutical standards, laboratory practices, proficiency, and regulatory compliance.

    Dr. Jones received her Doctorate in Analytical Chemistry from Arizona State University and was awarded a prestigious National Research Council postdoctoral fellowship at NIST.

    Katie Barnett

    Director, Membership and User Experience, CLSI

    Clinical and Laboratory Standards Institute

    Katie Barnett is CLSI's Director of Membership and User Experience and has been with CLSI for the past 14 years. She previously held the positions of Membership Director and Manager of Membership and Marketing.

    Jessica (Chumaceiro) Tredway

    Customer Relationship Manager, CLSI

    Clinical and Laboratory Standards Institute

    Jessica Tredway is CLSI's Customer Relationship Manager. Her responsibilities include building, retaining, maintaining, and fostering relationships between CLSI and its stakeholders, including members, customers, volunteers and vendors.

  • Contains 2 Component(s) Recorded On: 09/27/2022

    Learn how to use the 4th edition of EP14--Evaluation of Commutability of Processed Samples. EP14 provides guidance for evaluating the commutability of processed samples for determining if they behave differently than unprocessed patient samples when two quantitative measurement procedures are compared.

    Using EP14: Evaluation of Commutability of Processed Samples

    September 27, 1:00 PM US Eastern time

    Learn how to use the 4th edition of EP14--Evaluation of Commutability of Processed Samples. EP14 provides guidance for evaluating the commutability of processed samples for determining if they behave differently than unprocessed patient samples when two quantitative measurement procedures are compared.

    Learning Objectives:

    • Understanding commutability
    • Determine which type of processed samples may need to be evaluated for commutability
    • How to design the commutability evaluation study, including acceptance criteria
    • Running the study, then reviewing the results to see if data transformations are needed
    • Analyzing the data and evaluating commutability

    Speaker: Jeffrey R. Budd, PhD

    Jeffrey R. Budd, PhD

    Dr. Budd received his PhD in Biometry and Health Information Systems from the University of Minnesota. His entire career has been directed toward improving clinical diagnostics in lung function, cardiac electrophysiology, home health monitoring and finally in vitro diagnostics (IVD). He was Principal Biostatistician at Beckman Coulter for 20 years from which he retired 2 years ago.

    Besides an IVD biostatistical consulting practice, Dr. Budd actively participates in developing IVD international guidelines. This includes membership in the ISO TC212 working group 2 which published 17511 on metrological traceability and the IFCC working group on reference material commutability which published a series of papers on this topic. He also plays active roles in CLSI including as a member of the EP Expert Panel; as chair of the document development committees (DDC) for EP09 on measurement procedure comparison, EP12 on qualitative examinations and EP30 on commutable reference material; and as member of the DDCs for EP14 on processed sample commutability and for EP32 on metrological traceability.